OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
New and Emerging Systemic Therapeutic Options for Advanced Cholangiocarcinoma
Sara Massironi, Lorenzo Pilla, Alessandra Elvevi, et al.
Cells (2020) Vol. 9, Iss. 3, pp. 688-688
Open Access | Times Cited: 74
Sara Massironi, Lorenzo Pilla, Alessandra Elvevi, et al.
Cells (2020) Vol. 9, Iss. 3, pp. 688-688
Open Access | Times Cited: 74
Showing 1-25 of 74 citing articles:
Metabolic reprogramming in cholangiocarcinoma
Chiara Raggi, Maria Letizia Taddei, Colin Rae, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 3, pp. 849-864
Open Access | Times Cited: 98
Chiara Raggi, Maria Letizia Taddei, Colin Rae, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 3, pp. 849-864
Open Access | Times Cited: 98
Clinical treatment of cholangiocarcinoma: an updated comprehensive review
Alessandra Elvevi, Alice Laffusa, Miki Scaravaglio, et al.
Annals of Hepatology (2022) Vol. 27, Iss. 5, pp. 100737-100737
Open Access | Times Cited: 91
Alessandra Elvevi, Alice Laffusa, Miki Scaravaglio, et al.
Annals of Hepatology (2022) Vol. 27, Iss. 5, pp. 100737-100737
Open Access | Times Cited: 91
Aggregation-induced emission photosensitizer-based photodynamic therapy in cancer: from chemical to clinical
Zijuan Meng, Huiying Xue, Tingting Wang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 80
Zijuan Meng, Huiying Xue, Tingting Wang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 80
First-line Chemotherapy in Advanced Biliary Tract Cancer Ten Years After the ABC-02 Trial: “And Yet It Moves!”
Alessandro Rizzo, Giovanni Brandi
Cancer Treatment and Research Communications (2021) Vol. 27, pp. 100335-100335
Open Access | Times Cited: 81
Alessandro Rizzo, Giovanni Brandi
Cancer Treatment and Research Communications (2021) Vol. 27, pp. 100335-100335
Open Access | Times Cited: 81
Advances in targeted therapy of cholangiocarcinoma
Yuhang Li, Jianfeng Yu, Yujing Zhang, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 12
Yuhang Li, Jianfeng Yu, Yujing Zhang, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 12
Immune microenvironment of cholangiocarcinoma: Biological concepts and treatment strategies
Xianzhe Yu, Lingling Zhu, Ting Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Xianzhe Yu, Lingling Zhu, Ting Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Intrahepatic cholangiocarcinoma biomarkers: Towards early detection and personalized pharmacological treatments
Maurizio Capuozzo, Mariachiara Santorsola, Francesco Ferrara, et al.
Molecular and Cellular Probes (2024) Vol. 73, pp. 101951-101951
Open Access | Times Cited: 6
Maurizio Capuozzo, Mariachiara Santorsola, Francesco Ferrara, et al.
Molecular and Cellular Probes (2024) Vol. 73, pp. 101951-101951
Open Access | Times Cited: 6
Pathological, molecular, and clinical characteristics of cholangiocarcinoma: A comprehensive review
Mukul Vij, Yogesh Puri, Ashwin Rammohan, et al.
World Journal of Gastrointestinal Oncology (2022) Vol. 14, Iss. 3, pp. 607-627
Open Access | Times Cited: 24
Mukul Vij, Yogesh Puri, Ashwin Rammohan, et al.
World Journal of Gastrointestinal Oncology (2022) Vol. 14, Iss. 3, pp. 607-627
Open Access | Times Cited: 24
Role of molecular genetics in the clinical management of cholangiocarcinoma
Nicola Normanno, Erika Martinelli, Davide Melisi, et al.
ESMO Open (2022) Vol. 7, Iss. 3, pp. 100505-100505
Open Access | Times Cited: 23
Nicola Normanno, Erika Martinelli, Davide Melisi, et al.
ESMO Open (2022) Vol. 7, Iss. 3, pp. 100505-100505
Open Access | Times Cited: 23
Biomarkers for response to immunotherapy in hepatobiliary malignancies
Zhifei Lin, Lun‐Xiu Qin, Jinhong Chen
Hepatobiliary & pancreatic diseases international (2022) Vol. 21, Iss. 5, pp. 413-419
Closed Access | Times Cited: 23
Zhifei Lin, Lun‐Xiu Qin, Jinhong Chen
Hepatobiliary & pancreatic diseases international (2022) Vol. 21, Iss. 5, pp. 413-419
Closed Access | Times Cited: 23
Role of sex in liver tumor occurrence and clinical outcomes: A comprehensive review
Pierluigi Toniutto, Sarah Shalaby, Laura Mameli, et al.
Hepatology (2023) Vol. 79, Iss. 5, pp. 1141-1157
Open Access | Times Cited: 14
Pierluigi Toniutto, Sarah Shalaby, Laura Mameli, et al.
Hepatology (2023) Vol. 79, Iss. 5, pp. 1141-1157
Open Access | Times Cited: 14
Artificial Intelligence-Based Opportunities in Liver Pathology—A Systematic Review
Pierre Allaume, Noémie Rabilloud, Bruno Turlin, et al.
Diagnostics (2023) Vol. 13, Iss. 10, pp. 1799-1799
Open Access | Times Cited: 13
Pierre Allaume, Noémie Rabilloud, Bruno Turlin, et al.
Diagnostics (2023) Vol. 13, Iss. 10, pp. 1799-1799
Open Access | Times Cited: 13
HCG18 Promotes Cell Proliferation and Stemness in Cholangiocarcinoma via the miR-194-5p/KRT18/MAPK Signaling
Guodong Tian, Lu Zuo, Jie Li, et al.
Biochemical Genetics (2025)
Closed Access
Guodong Tian, Lu Zuo, Jie Li, et al.
Biochemical Genetics (2025)
Closed Access
Triiodothyronine promotes the proliferation and chemoresistance of cholangiocarcinoma cells via HIF-1α/Glut1-stimulated glycolysis
Dihua Huang, Feng Xu, Luohang Xu, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 5, pp. 167814-167814
Closed Access
Dihua Huang, Feng Xu, Luohang Xu, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 5, pp. 167814-167814
Closed Access
Adjuvant and neoadjuvant therapy for biliary tract cancer: a review of clinical trials
Satoshi Nara, Minoru Esaki, Daisuke Ban, et al.
Japanese Journal of Clinical Oncology (2020) Vol. 50, Iss. 12, pp. 1353-1363
Open Access | Times Cited: 32
Satoshi Nara, Minoru Esaki, Daisuke Ban, et al.
Japanese Journal of Clinical Oncology (2020) Vol. 50, Iss. 12, pp. 1353-1363
Open Access | Times Cited: 32
Immune Checkpoint Inhibitors: The Emerging Cornerstone in Cholangiocarcinoma Therapy?
María Gutiérrez‐Larrañaga, Elena González-López, Adriel Roa-Bautista, et al.
Liver Cancer (2021) Vol. 10, Iss. 6, pp. 545-560
Open Access | Times Cited: 30
María Gutiérrez‐Larrañaga, Elena González-López, Adriel Roa-Bautista, et al.
Liver Cancer (2021) Vol. 10, Iss. 6, pp. 545-560
Open Access | Times Cited: 30
Targeting Wnt/β-Catenin Pathways in Primary Liver Tumours: From Microenvironment Signaling to Therapeutic Agents
Federico Selvaggi, Teresa Catalano, Roberto Cotellese, et al.
Cancers (2022) Vol. 14, Iss. 8, pp. 1912-1912
Open Access | Times Cited: 20
Federico Selvaggi, Teresa Catalano, Roberto Cotellese, et al.
Cancers (2022) Vol. 14, Iss. 8, pp. 1912-1912
Open Access | Times Cited: 20
FGFR Inhibitors in Cholangiocarcinoma—A Novel Yet Primary Approach: Where Do We Stand Now and Where to Head Next in Targeting This Axis?
Paulina Chmiel, Katarzyna Gęca, Karol Rawicz‐Pruszyński, et al.
Cells (2022) Vol. 11, Iss. 23, pp. 3929-3929
Open Access | Times Cited: 20
Paulina Chmiel, Katarzyna Gęca, Karol Rawicz‐Pruszyński, et al.
Cells (2022) Vol. 11, Iss. 23, pp. 3929-3929
Open Access | Times Cited: 20
Preoperative predictors for non-resectability in perihilar cholangiocarcinoma
Carlos Constantin Otto, Anna Mantas, Lara R. Heij, et al.
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Carlos Constantin Otto, Anna Mantas, Lara R. Heij, et al.
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Molecular signatures of intrahepatic Cholangiocarcinoma: Role in targeted therapy selection
Tetiana Glushko, James Costello, Ranjit S. Chima, et al.
European Journal of Radiology (2025), pp. 112056-112056
Closed Access
Tetiana Glushko, James Costello, Ranjit S. Chima, et al.
European Journal of Radiology (2025), pp. 112056-112056
Closed Access
Identification of immune related gene signature for predicting prognosis of cholangiocarcinoma patients
Zijian Zhang, Yun-peng Huang, Zhongtao Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Zijian Zhang, Yun-peng Huang, Zhongtao Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Circ‐LAMP1 contributes to the growth and metastasis of cholangiocarcinoma via miR‐556‐5p and miR‐567 mediated YY1 activation
Yi Xu, Ping Gao, Zhidong Wang, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 7, pp. 3226-3238
Open Access | Times Cited: 21
Yi Xu, Ping Gao, Zhidong Wang, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 7, pp. 3226-3238
Open Access | Times Cited: 21
Management of Intrahepatic Cholangiocarcinoma
Sudha Kodali, Akshay Shetty, Soumya Shekhar, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 11, pp. 2368-2368
Open Access | Times Cited: 21
Sudha Kodali, Akshay Shetty, Soumya Shekhar, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 11, pp. 2368-2368
Open Access | Times Cited: 21
Real-world outcomes of patients with advanced intrahepatic cholangiocarcinoma treated with programmed cell death protein-1-targeted immunotherapy
Min Deng, Shaohua Li, Qiaoxuan Wang, et al.
Annals of Medicine (2022) Vol. 54, Iss. 1, pp. 803-811
Open Access | Times Cited: 15
Min Deng, Shaohua Li, Qiaoxuan Wang, et al.
Annals of Medicine (2022) Vol. 54, Iss. 1, pp. 803-811
Open Access | Times Cited: 15
An Insight into the Novel Immunotherapy and Targeted Therapeutic Strategies for Hepatocellular Carcinoma and Cholangiocarcinoma
Eleni-Myrto Trifylli, Evangelos Koustas, Nikolaos Papadopoulos, et al.
Life (2022) Vol. 12, Iss. 5, pp. 665-665
Open Access | Times Cited: 14
Eleni-Myrto Trifylli, Evangelos Koustas, Nikolaos Papadopoulos, et al.
Life (2022) Vol. 12, Iss. 5, pp. 665-665
Open Access | Times Cited: 14
